Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

Clara E Busse; Chase D Latour; Sara Z Dejene; Andrea K Knittel; Mollie E Wood; Alan C Kinlaw; Mekhala V Dissanayake

doi:10.1016/j.conx.2023.100101

Incidence of new outpatient long-acting reversible contraceptive insertions among a commercially insured, US population from 2010 to 2020

Contracept X. 2023 Sep 17:5:100101. doi: 10.1016/j.conx.2023.100101. eCollection 2023.

Authors

Clara E Busse^{1

2}, Chase D Latour^{3

4}, Sara Z Dejene³, Andrea K Knittel⁵, Mollie E Wood³, Alan C Kinlaw^{4

6}, Mekhala V Dissanayake^{2

3}

Affiliations

¹ Department of Maternal and Child Health, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
² Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
³ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
⁴ Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
⁵ Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
⁶ Division of Pharmaceutical Outcomes and Policy, University of North Carolina School of Pharmacy, Chapel Hill, NC, United States.

Abstract

Objectives: Characterize new use of long-acting reversible contraceptives (LARCs), highly effective contraceptive methods, in a broad population over time.

Study design: We constructed a retrospective cohort of commercially insured individuals aged 15 to 54 years from 2010 to 2020 and estimated monthly incidence of new LARC insertions.

Results: The monthly standardized incidence increased from 6.0 insertions per 10,000 individuals in January 2010 to 14.1 in December 2020, with a dip in insertions after March 2020. Hormonal intrauterine devices were consistently the most inserted LARC; implants were increasingly favored over time.

Conclusions: LARCs are increasingly popular forms of contraception among commercially insured individuals.

Implications: Given the increasing popularity, ensuring access to LARCs is critical.

Keywords: Contraception; Family planning; Hormonal implants; Insurance claims; Intrauterine devices; Long-acting reversible contraceptives.

Abstract

Grants and funding